
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

September 27, 2022
On Louis Dron et al., “Data Capture and Sharing in the COVID-19 Pandemic: A Cause for Concern,” The Lancet 4 (10) (2022)
Read article

September 8, 2022
Cytel Present at the ASA Biopharmaceutical Section Regulatory Workshop
The American Statistical Association Biopharmaceutical Section, in cooperation with the FDA Statistical Association,...
Read article

August 25, 2022
Cytel Presents at ICPE 2022
The International Society for Pharmacoepidemiology is hosting its “ICPE 2022: Advancing Pharmacoepidemiology and...
Read article


June 29, 2022
Platform Trials, Master Protocols, and Challenges in Execution
How can we build an efficient statistical protocol for a clinical trial, if we do not know the therapies that will be...
Read article

May 26, 2022
Method of Estimation with application to the COVID-19 Pandemic
When constructing estimands a key question that arises is how to handle intercurrent events and missing data. In a...
Read article

May 4, 2021
New Publication on Adaptive Platform Trials
As healthcare systems across the world, continue to grapple with the pressures of COVID-19, Cytel advances yet another...
Read article

May 28, 2020
Implications for the Future of Drug Development in Emerging Economies
On May 7, Cytel and Certara conducted a virtual panel discussion on new opportunities and implications for the future...
Read article

May 14, 2020
Weekly COVID-19 Trial Tracker Updates
This has been an exciting week for COVID-19 studies. We learned that several Cytel clients who have designed new...
Read article

May 12, 2020
Oncology Trial Design & Development Webinar Series
In our previous blog, “Remote Working Arrangement – How to get it right?”, we talked about how the need for social...
Read article

May 7, 2020
Weekly Insights from the COVID-19 Trial Tracker: Oxford Vacine Study
There are now over 950 trials registered, which means that 250 new trials were registered in the past week. Only 540 of...
Read article

May 7, 2020
COVID-19: Trials, Designs and Tools for Promising Results - A Virtual Panel Discussion
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread...
Read article

May 1, 2020
Weekly Insights from Cytel's COVID-19 Trial Tracker
There are currently 665 trials registered at Cytel’s COVID-19 Trial Tracker, a jump of over 100 trials in the past two...
Read article

April 23, 2020
Weekly Insights from the COVID-19 Trial Tracker
Every Week Cytel Brings You Further Insights from the COVID-19 Trial Tracker From April 8 through April 17, the number...
Read article

April 14, 2020
Early Insights from Cytel’s New COVID-19 Trial Tracker
Last week Cytel launched a COVID-19 Trial Tracker, an Open Access tool to track the global response to the coronavirus...
Read article

April 2, 2020
Remote Working Arrangement – How to get it right?
On March 16, the World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, in his media...
Read article

March 26, 2020
Cytel's Response: EMA Points to consider on implications of COVID-19
Further regulatory guidance has been released concerning the implications of the Coronavirus disease (COVID-19) on...
Read article

March 23, 2020
Cytel's Response: EMA Guidance on the Management of Clinical Trials During the COVID-19 (Coronavirus) Pandemic
On March 20th the European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agency (HMA)...
Read article

March 19, 2020
Cytel's Response: FDA Guidance on Conduct of Clinical Trials during the COVID-19 Pandemic
The FDA issued a guidance yesterday on how the COVID-19 Pandemic may affect the conduct of clinical trials. Below are...
Read article